Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells

Human Gene Therapy

Volumn 10, Issue 16, 1999, Pages 2709-2717

  Gonzalez, Ricardo ^a   Vereecque, Rodolphe ^a   Wickham, Thomas J ^b   Facon, Thierry ^c   Hetuin, Dominique ^a   Kovesdi, Imre ^b   Bauters, Francis ^c   Penaux, Pierre ^a,c   Quesnel, Bruno ^a,c,d  

^a INSERM   (France)

^b GENVEC INC   (United States)

^c CHU   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEPARIN LYASE; RECOMBINANT PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MYELOMA CELL; NONHUMAN; TRANSGENE; VIRUS ADSORPTION; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE MARROW CELLS; CHONDROITINASES AND CHONDROITIN LYASES; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HEPARIN LYASE; HUMANS; MULTIPLE MYELOMA; NEURAMINIDASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0033231102     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016753     Document Type: Article

References (20)

1. BERGELSON, J.M., KRITHIVAS, A., CELI, L., DROGUETT, G., HORWITZ, M.S., WICKHAM, T., CROWELL, R.L., and FINBERG, R.W. (1998). The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72, 415-419.
2. BREGNI, M., SHAMMAH, S., MALAFFO, F., DI NICOLA, M., MILANESI, M., MAGNI, M., MATTEUCCI, P., RAVAGNANI, F., JORDAN, C.T., SIENA, S., and GIANNI, A.M. (1998). Adenovirus vectors for gene transduction into mobilized blood CD34+ cells. Gene Ther. 5, 465-472.
3. DE WYNTER, E.A., BUCK, D., HART, C., HEYWOOD, R., COUTINHO, L.H., CLAYTON, A., RAFFERTY, J.A., BURT, D., GUENECHEA, G., BUEREN, J.A., GAGEN, D., FAIRBAIRN, L.J., LORD, B.I., and TESTA, N.G. (1998). CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16, 387-396. [In Process Citation]
4. DHODAPKAR, M.V., ABE, E., THEUS, A., LACY, M., LANGFORD, J.K., BARLOGIE, B., and SANDERSON, R.D. (1998). Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation. Blood 91, 2679-2688.
5. DRANOFF, G. (1998). Cancer gene therapy: Connecting basic research with clinical inquiry. J. Clin. Oncol. 16, 2548-2556.
6. GONZALEZ, R., VEREECQUE, R., WICKHAM, T., VANRUMBEKE, M., KOVESDI, I., BAUTERS, F., FENAUX, P., and QUESNEL, B. (1999). Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther. 6, 314-320.
7. KOPANTZEV, E., ROSCHKE, V., and RUDIKOFF, S. (1998). Interleukine 2 mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum. Gene Ther. 9, 13-19.
8. MARINI, F., YU, Q., WICKHAM, T., KOVESDI, T., and ANDREEFF, M. (1998). High efficiency gene transfer into human CD34 progenitor cells using the genetically retargeted adenoviral vector Ad pK7. In Blood 92: American Society of Hematology, Fortieth Annual Meeting, 468a.
9. MARAGLIA, S., GODFREY, W., YIN, A.H., ATKINS, K., WARNKE, R., HOLDEN, J.T., BRAY, R.A., WALLER, E.K., and BUCK, D.W. (1997). A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90, 5013-5021.
10. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
11. PAILLARD, F. (1998). Immuno-gene therapy for myeloma using cytokines. Hum. Gene Ther. 9, 1-2.
12. PRINCE, H.M., DESSUREAULT, S., GALLINGER, S., KRAJDEN, M., SUTHERLAND, D.R., ADDISON, C., ZHANG, Y., GRAHAM, F.L., and STEWART, A.K. (1998). Efficient adenovirus-mediated gene expression in malignant human plasma cells: Relative lymphoid cell resistance. Exp. Hematol. 26, 27-36.
13. RIDLEY, R.C., XIAO, H., HATA, H., WOODLIFF, J., EPSTEIN, J., and SANDERSON, R.D. (1993). Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81, 767-774.
14. STEWART, A.K., SCHIMMER, A.D., BAILEY, D.J., DUBE, I.D., CAPPE, D., MOEN, R.C., GAULDIE, J., and GRAHAM, F.L. (1998). In vivo adenoviral-mediated gene transfer of interleukin-2 in cutaneous plasmacytoma. Blood 91, 1095-1097. [Letter]
15. TEOH, G., CHEN, L., URASHIMA, M., TAI, Y.T., CELI, L.A., CHEN, D., CHAUHAN, D., OGATA, A., FINBERG, R.W., WEBB, I.J., KUFE, D.W., and ANDERSON, K.C. (1998). Adenovirus vector-based purging of multiple myeloma cells. Blood 92, 4591-4601. [In Process Citation]
16. TURNER, J.G., TAN, J., CRUCIAN, B.E., SULLIVAN, D.M., BALLESTER, O.F., DALTON, W.S., YANG, N.S., BURHOLDER, J.K., and YU, H. (1998). Broadened clinical utility of gene gun mediated granulocyte macrophage colony stimulating factor cDNA based tumor cell vaccines as demonstrated with a mouse myeloma model. Hum. Gene Ther. 9, 1121-1130.
17. WATTEL, E., VANRUMBEKE, M., ABINA, M.A., CAMBIER, N., PREUDHOMME, C., HADDADA, H., and FENAUX, P. (1996). Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia 10, 171-174.
18. WICKHAM, T.J., ROELVINK, P.W., BROUGH, D.E., and KOVESDI, I. (1996). Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnol. 14, 1570-1573.
19. WICKHAM, T.J., TZENG, E., SHEARS, L.L., II, ROELVINK, P.W., LI, Y., LEE, G.M., BROUGH, D.E., LIZONOVA, A., and-KOVESDI, I. (1997). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71, 8221-8229.
20. YIN, A.H., MIRAGLIA, S., ZANJANI, E.D., ALMEIDA-PORADA, G., OGAWA, M., LEARY, A.G., OLWEUS, J., KEARNEY, J., and BUCK, D.W. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002-5012.